AbbVie

+$0.73 (+0.68%) As of 1:39 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AbbVie and other ETFs, options, and stocks.

About ABBV

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions.

CEO
Richard A. Gonzalez
Employees
47,000
Headquarters
North Chicago, Illinois
Founded
2011

ABBV Key Statistics

Market Cap
192.86B
Price-Earnings Ratio
29.20
Dividend Yield
4.69
Average Volume
5.51M
High Today
$109.14
Low Today
$108.22
Open Price
$108.39
Volume
399.46K
52 Week High
$121.53
52 Week Low
$79.11

ABBV News

Benzinga24h

Price Over Earnings Overview: AbbVie

In the current market session, AbbVie Inc. (NYSE:ABBV) is trading at $109.16, after a 0.30% decrease. However, over the past month, the stock increased by 0.29%
Simply Wall StOct 25

Investors in AbbVie have made a strong return of 138% over the past five years

The main point of investing for the long term is to make money. But more than that, you probably want to see it rise more than the market average. Unfortunately

ABBV Earnings

$0.00
$1.08
$2.15
$3.23
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
$3.23 per share
Actual
Available Oct 29, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure